Ambuja Cements Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
AMBUJACEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ambuja Cements has filed a quarterly compliance statement confirming that there is no deviation or variation in the use of funds raised through a preferential issue of equity shares (on conversion of warrants) for the quarter ended September 30, 2025. The company had raised a total of Rs 15,000.046 crores in two tranches — Rs 6,660.946 crores on March 28, 2024 and Rs 8,339.099 crores on April 17, 2024. Of this, Rs 14,795.1 crores had been utilised by June 30, 2025. The funds were earmarked for capital expenditure, de-bottlenecking, logistics infrastructure, digitising logistics, ESG compliance, acquisitions, working capital, technology investment, and general corporate purposes. The Audit Committee reviewed and approved the statement, with no comments or objections from auditors.
This is a routine positive compliance disclosure confirming that the company is deploying the large preferential issue funds as originally disclosed to shareholders, with no misuse or diversion. It reinforces governance credibility but is unlikely to move the stock price on its own.